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A B S T R A C T
Plants are an excellent source of drug leads. However availability is limited by access to source species, low
abundance and recalcitrance to chemical synthesis. Although plant genomics is yielding a wealth of genes for
natural product biosynthesis, the translation of this genetic information into small molecules for evaluation as
drug leads represents a major bottleneck. For example, the yeast platform for artemisinic acid production is
estimated to have taken>150 person years to develop. Here we demonstrate the power of plant transient
transfection technology for rapid, scalable biosynthesis and isolation of triterpenes, one of the largest and most
structurally diverse families of plant natural products. Using pathway engineering and improved agro-inﬁltra-
tion methodology we are able to generate gram-scale quantities of puriﬁed triterpene in just a few weeks. In
contrast to heterologous expression in microbes, this system does not depend on re-engineering of the host. We
next exploit agro-infection for quick and easy combinatorial biosynthesis without the need for generation of
multi-gene constructs, so aﬀording an easy entrée to suites of molecules, some new-to-nature, that are re-
calcitrant to chemical synthesis. We use this platform to purify a suite of bespoke triterpene analogs and de-
monstrate diﬀerences in anti-proliferative and anti-inﬂammatory activity in bioassays, providing proof of con-
cept of this system for accessing and evaluating medicinally important bioactives. Together with new genome
mining algorithms for plant pathway discovery and advances in plant synthetic biology, this advance provides
new routes to synthesize and access previously inaccessible natural products and analogs and has the potential to
reinvigorate drug discovery pipelines.
1. Introduction
The Plant Kingdom harbors an enormous reservoir of diverse che-
micals. Accessing these molecules promises to reinvigorate drug dis-
covery pipelines and provide novel routes to synthesize complex com-
pounds that are beyond the reach of synthetic chemistry Anarat-
Cappillino and Sattely, 2014). Although breakthroughs in DNA se-
quencing technology and bioinformatics have accelerated discovery of
candidate genes for new natural product pathways, eﬀective harnessing
of plant metabolic diversity will require: i) a quick and easy method to
rapidly screen combinations of enzyme-encoding genes for production
of novel structures by expression in a suitable heterologous host, and ii)
the capability to purify suites of structural variants of these compounds
in suﬃcient quantities for evaluation in bioactivity assays.
Microorganisms, particularly yeasts, have proven to be useful het-
erologous hosts for expression of several plant natural product path-
ways, including the artemisinin precursor artemisinic acid (Paddon
et al., 2013), opioids (DeLoache et al., 2015; Galanie et al., 2015; Li and
Smolke, 2016) and monoterpene indole alkaloids (Brown et al., 2015;
Qu et al., 2015), and can be used for industrial-scale production of high-
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value plant products. However, despite some successes, many meta-
bolites have only been produced at low levels in yeasts and optimiza-
tion is far from trivial. For example, the development of a yeast plat-
form for the production of artemisinic acid is estimated to have taken
more than 150 person years (Kwok, 2010). Making microbes into eﬃ-
cient factories for the production of heterologous metabolites is hin-
dered by lack of fundamental knowledge about cellular processes
(Nielsen and Keasling, 2016).
Plants have a number of advantages as heterologous hosts for me-
tabolic engineering. They require only simple inorganic nutrients,
water, carbon dioxide and sunlight for eﬃcient growth. They are also
more amenable to expression of genes of plant origin than microbes
since they support correct mRNA and protein processing, protein lo-
calisation and metabolic compartmentalisation, and already have many
of the necessary metabolic precursors and co-enzymes. Species of to-
bacco are relatively easy and fast to transform by the integration of new
genes into the genome but high yields can also be achieved in just a few
days through transient expression following inﬁltration into the leaves
of a culture of Agrobacterium tumefaciens carrying genes of interest on a
binary plasmid vector, a process commonly known as agro-inﬁltration.
Nicotiana benthamiana, a wild relative of tobacco, is particularly
amenable to agro-inﬁltration-mediated transient expression and is
currently being used for commercial production of ﬂu vaccines
(Marsian and Lomonossoﬀ, 2016). The expression process is rapid,
taking only 5–6 days from inﬁltration of leaves with A. tumefaciens
strains harboring expression constructs to extraction of plant tissue.
Importantly, combinations of genes can be co-expressed without the
need for making multi-gene vectors simply by co-inﬁltrating multiple A.
tumefaciens strains containing diﬀerent expression constructs. Although
various plant natural product pathways have previously been en-
gineered by transient expression in this plant (Andersen-Ranberg et al.,
2016; Geisler et al., 2013; Geu-Flores et al., 2009; Khakimov et al.,
2015; Miettinen et al., 2014; Polturak et al., 2016; Rajniak et al., 2015;
Wang et al., 2016), the levels achieved are usually in the microgram
range. Here, we have optimized the N. benthamiana platform for pro-
duction of up to gram-scale amounts of puriﬁed triterpene, and have
demonstrated the power of this transient expression system for rapid
and facile combinatorial biosynthesis by generating over 40 diﬀerent
types of oxygenated triterpene analogs. We further show the potential
of this strategy for investigating structure-activity relationships in
bioassays. This overall strategy will greatly accelerate systematic in-
vestigation of the vast array of triterpene diversity found in the Plant
Kingdom by enabling the outputs of plant genomics to be translated
into puriﬁed compounds for evaluation as drug leads and for other
applications.
2. Results and discussion
2.1. Pathway engineering for increased triterpene yield in N. benthamiana
The triterpenes are one of the largest classes of plant natural pro-
ducts (> 20,000 reported to date) and are of considerable interest as
potential drug leads (Hill and Connolly, 2012; Moses et al., 2014a).
However few hypotheses exist regarding links between structure and
activity because of the lack of available suites of structural analogs for
bioactivity evaluation. These compounds are synthesized from the
mevalonate pathway by cyclisation of the isoprenoid precursor 2,3-
oxidosqualene to diverse triterpene scaﬀolds, the most common of
which is β-amyrin (Thimmappa et al., 2014) (Fig. 1a). These scaﬀolds
are then further modiﬁed by cytochromes P450 (CYPs) and other tai-
loring enzymes. Although yeast has been used as a heterologous ex-
pression host to make and modify triterpene scaﬀolds (Fukushima et al.,
2013; Moses et al., 2014b; Thimmappa et al., 2014) the potential of in
planta production has not been fully explored. We previously showed
that transient expression of the oat β-amyrin synthase SAD1 in N.
benthamiana leads to accumulation of β-amyrin in inﬁltrated leaf tissue
(Geisler et al., 2013). Since precursor availability may be limiting, we
co-expressed SAD1 with diﬀerent upstream mevalonate pathway genes
to determine the eﬀects on triterpene production. Farnesyl diphosphate
synthase (FPS) and squalene epoxidase (SQE) had little or no eﬀect on
β-amyrin content, while squalene synthase (SQS) gave a modest in-
crease (Fig. 1b). The largest eﬀect was seen with a feedback-insensitive
version of HMG-CoA reductase (tHMGR), which gave a four-fold in-
crease (Fig. 1b, c; Fig S1). CYP51H10 oxygenates β-amyrin at two po-
sitions to give 12,13-epoxy, 16-hydroxy-β-amyrin (EpHβA) (Fig. 1d)
(Geisler et al., 2013). We used this CYP to evaluate the eﬀects of co-
expression with tHMGR on production of oxidized triterpene scaﬀolds
by expressing SAD1 and CYP51H10 in N. benthamiana leaves with or
without tHMGR, and showed that inclusion of tHMGR led to an increase
in EpHβA production of ~10-fold (Fig. 1e,f; Fig S1). Thus, co-expres-
sion with tHMGR proved suﬃcient to signiﬁcantly increase triterpene
production in this transient plant expression system.
2.2. Gram-scale triterpene production using vacuum inﬁltration
We next used tHMGR in combination with Sad1 to investigate the
potential of the transient plant expression platform for preparative-
scale triterpene production. Our experiments up to this point had relied
on inﬁltration of N. benthamiana leaves with A. tumefaciens cells using a
syringe without a needle. To increase our capacity for eﬀective leaf
inﬁltration we designed a device that would enable eﬃcient vacuum
inﬁltration of 4–6 plants simultaneously (Fig. 2a). Preliminary experi-
ments using a reporter construct showed that this method resulted in
very good GFP expression in inﬁltrated leaves (Fig. 2b). We then carried
out batch-wise inﬁltration of ~460 N. benthamiana plants with a mix-
ture of two A. tumefaciens strains carrying CPMV-HT expression con-
structs for the tHMGR and Sad1 genes, respectively, and puriﬁed>
800 mg of β-amyrin as white needles (Fig. 2c). The crystals were es-
timated to have a purity of> 98% by HPLC-CAD (Fig S2a). Given that
the mother liquor still contained>150 mg of β-amyrin (Fig S2b), we
estimate the total amount of β-amyrin recovered to be in the region of
one gram, which corresponds to 0.4% dry leaf weight. These results
demonstrate the potential of the N. benthamiana transient expression
system for preparative-scale biosynthesis, with the opportunity for
further scale-up, for instance by using larger vacuum inﬁltration de-
vices.
2.3. Combinatorial biosynthesis using agro-inﬁltration provides rapid access
to novel molecular diversity
Selective functionalization of triterpene scaﬀolds using synthetic
chemistry is limited by lack of available reactive groups. Within the last
few years considerable advances have been made in identifying and
characterizing triterpene biosynthetic enzymes from plants (Biazzi
et al., 2015; Boutanaev et al., 2015; Carelli et al., 2011; Fukushima
et al., 2011, 2013; Geisler et al., 2013; Itkin et al., 2016; Khakimov
et al., 2015; Miettinen et al., 2017; Moses et al., 2014b, 2014c, 2015a,
2015b; Salmon et al., 2016; Seki et al., 2008, 2015; Shang et al., 2014;
Shibuya et al., 2006; Thimmappa et al., 2014; Yasumoto et al., 2016;
Zhang et al., 2016), opening up opportunities to harness enzymes from
nature for systematic investigation of a much broader sector of biolo-
gically relevant chemical space than can be achieved using conven-
tional chemistry.
Since agro-inﬁltration enables co-expression of genes of interest
without the need to make multi-gene constructs through co-inﬁltration
of A. tumefaciens strains harboring diﬀerent expression constructs, we
evaluated the potential of the transient N. benthamiana expression
system for combinatorial biosynthesis. We selected ﬁve CYPs from di-
verse plant species (oat, licorice, soy bean, barrelclover) that had pre-
viously been shown to oxidase β-amyrin at diﬀerent scaﬀold positions
(Carelli et al., 2011; Fukushima et al., 2011; Geisler et al., 2013; Moses
et al., 2014c; Seki et al., 2008; Shibuya et al., 2006) and co-expressed
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each of these with tHMGR and SAD1 in N. benthamiana. All were
functional and most converted the majority of available β-amyrin to the
expected products (Fig. 3, blue circle; Fig S3). We then evaluated all ten
possible pairwise combinations of these CYPs for further scaﬀold
modiﬁcation. A total of 41 products were detected across the diﬀerent
combinations (Figs S4-13; Table S1), many of which represented pre-
viously unreported structures. The major products generated are shown
in Fig. 3. Compounds 7–10 were as predicted based on the known ac-
tivities of the enzymes and matched the respective electron ionization
spectra of previously reported triterpenes (Table S1; Figs S4-7). Com-
pounds 11–17 were puriﬁed in quantities of 3.5–46 mg (Table S2) and
their structures determined by NMR following initial GC-MS analysis
(Figs S8-12; Tables S3-8). Two of these structures had previously been
reported, whilst to our knowledge the other ﬁve had not (Table S1).
These novel triterpenes included a C12β-hydroxyl, C13-C28-γ-lactone
generated by co-expressing CYP51H10 with CYP716A12 (compound
17; Fig. 3), a product that has presumably arisen through in-
tramolecular reactivity of the introduced functional groups. These
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examples illustrate the power of this highly versatile approach for rapid
combinatorial expression and the potential for generating new mole-
cules using biosynthetic enzymes from diverse plant species.
2.4. Preparative access to triterpene analogs allows investigation of
structure-activity relationships
Oleanolic acid, a naturally occurring oxidized form of β-amyrin, has
been used as a starting point to generate triterpene drug leads such as
bardoxolone methyl (a potent activator of the Nrf2 pathway, currently
in phase 2 clinical trials) using synthetic chemistry (Liby and Sporn,
Fig. 2. Generation of gram quantities of triterpene
using vacuum inﬁltration a, Vacuum inﬁltration of
N. benthamiana plants. Plants are retained by a be-
spoke holder, inverted into a bath containing 10 L of
A. tumefaciens suspension, and a vacuum applied.
Upon release of the vacuum the inﬁltration process is
complete. b, GFP expression in leaves from a va-
cuum-inﬁltrated plant 5 days after inﬁltration
(leaves arranged from top left to bottom right in
descending order of their height on the plant). The
youngest leaves (top left) were formed post-inﬁltra-
tion. c, β-Amyrin puriﬁed from vacuum-inﬁltrated
plants following transient expression.
Fig. 3. Combinatorial biosynthesis of oxygenated triterpenes in N.
benthamiana. The major products of combinatorial biosynthesis
are shown in the outer circle. The structures of compounds 11–17
were determined by NMR following initial GC-MS analysis (Figs
S8-13; Tables S1-8). Structures 7–10 were inferred by GC-MS,
based on comparison with previously reported compounds (Table
S1; Figs S4-7). GC-MS also revealed a further 30 new unidentiﬁed
products across the diﬀerent enzyme combinations (Table S1).
Similar results were obtained when β-amyrin synthase was co-
expressed with the diﬀerent CYP combinations in yeast (Fig. S14).
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2012). However, these initial endeavors were constrained by lack of
oxidative functionality on the scaﬀold. Using our toolkit of triterpene
biosynthetic enzymes in combination with plant transient expression
technology we have greatly expanded the possibility for creating di-
versiﬁed suites of oxidized variants in suﬃcient quantities for bioas-
says. As a proof of concept, we assayed a series of oxygenated β-amyrin
analogs that we had puriﬁed from our in planta expression system along
with several commercially available triterpenes (oleanolic acid, ery-
throdiol, glycyrrhetinic acid) and demonstrated diﬀerences in anti-
proliferative and anti-inﬂammatory activity using human cell lines
(Fig. 4). Although the activity of these molecules was orders of mag-
nitude lower than that of bardoxolone methyl, these experiments de-
monstrate that small diﬀerences in the type and position of oxidation
can result in marked diﬀerences in bioactivity and open up opportu-
nities to further diversify the oleanane scaﬀold (by further metabolic
engineering and/or synthetic chemistry), so enabling systematic in-
vestigation of structure-activity relationships for pharmaceutical ap-
plications.
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3. Conclusions
There are more than 400,000 species of ﬂowering plants in the
world. The vast majority of these (> 99.9%) have not yet been se-
quenced. Over 50% of drugs in current use are derived from natural
products (Harvey et al., 2015). As methods for sequencing and mining
plant genomes are becoming faster, cheaper and more eﬀective, can-
didate biosynthetic pathways for multitudes of new natural products
will undoubtedly be revealed (Medema and Osbourn, 2016; Owen
et al., 2017).
Plants have many inherent advantages over microbes for expression
of genes, enzymes and pathways of plant origin. However, they have
historically been overlooked as eﬃcient heterologous hosts for small
molecule production, in part due to the technical and regulatory chal-
lenges and length of time associated with generation of high-level
producing stable transgenic lines. Although N. benthamiana has pre-
viously been used as a host for transient expression of terpene biosyn-
thetic genes (primarily for mono-, di- and sesquiterpenes), the esti-
mated levels as assessed by GC- or LC-based quantiﬁcation of leaf
extracts were in the region of 0.6 μg – 1 mg/g dry weight. Most of these
are theoretical yields since few of these products were puriﬁed, which
would inevitably result in signiﬁcant yield loss (Table S11). In a proof
of concept experiment we previously showed that we could purify
20 mg of triterpene from 17 g of leaf tissue following transient ex-
pression in N. benthamiana (an actual yield of 1.18 mg/g dry weight)
(Geisler et al., 2013). Here we demonstrate optimization of this ex-
pression system through a combination of pathway engineering and
improvement of the agro-inﬁltration process. We ﬁrstly show that in-
clusion of a feedback insensitive form of HMG-CoA reductase in our co-
inﬁltration experiments increased the yields of simple and oxidized
triterpenes by 4–10 fold. Secondly, we develop a highly eﬀective va-
cuum inﬁltration process and demonstrate that this can be used for
inﬁltration of whole plants rather than individual leaves, to yield gram-
scale quantities of puriﬁed triterpene. Thirdly, we show that this tran-
sient expression system can be used to rapidly generate suites of pur-
iﬁed triterpenes and analogs, simply by mixing A. tumefaciens strains
carrying diﬀerent expression constructs.
Our work demonstrates the power and potential of this novel plant
transient transfection technology for rapid preparative access to plant-
derived molecules. This technology, in combination with advances in
commercial DNA synthesis and establishment of standardized methods
and pipelines for modular and rapid construction of vectors for het-
erologous expression in plants using synthetic biology approaches
(Patron et al., 2015; Owen et al., 2017), opens up unprecedented op-
portunities for harnessing new molecular diversity for drug discovery,
producing normally low-abundance molecular entities in quantity
(enablement of bioprospecting hits), and improving on promising nat-
ural product leads (lead optimization for complex biomolecules).
4. Materials and methods
4.1. Generation of Gateway Entry constructs
Oligonucleotide primers were purchased from Sigma-Aldrich and all
PCR steps were performed using Phusion polymerase (New England
Biolabs). The oat HMGR, FPS, SQS and SQE gene sequences were
identiﬁed from an A. strigosa root tip 454 transcriptomic database
(Kemen et al., 2014) (GenBank accession numbers tHMGR – KY284573;
FPS1 – KY284574; SQS1 – KY284575; SQE1 – KY284576). A. strigosa
root tip RNA extraction and cDNA synthesis was performed as described
previously (Kemen et al., 2014). The partial HMGR gene lacking the
ﬁrst 417 nucleotides (tHMGR) was ampliﬁed from this cDNA using
primers P1 + P2 (Table S10) and cloned into the Gateway Entry vector
pENTR-D-TOPO (Invitrogen) according to the manufacturer's instruc-
tions. Full length coding sequences of FPS, SQS and SQE were ampliﬁed
from cDNA by PCR using primers P3 + P4, P5 + P6 and P7 + P8
respectively (Table S10). The ampliﬁed products were inserted into a
Zero Blunt TOPO vector (Invitrogen) according to the manufacturer's
instructions. These vectors were then used as templates for PCR to
generate Gateway-compatible inserts using primers P9 + P10, P11 +
P12 and P13 + P14 respectively (Table S10). The ampliﬁed products
were cloned into the pDONR207 vector using BP clonase II enzyme mix
(Invitrogen) according to the manufacturer's instructions. SAD1 and
CYP51H10 Gateway inserts were likewise ampliﬁed from vectors as
described previously (Geisler et al., 2013) using the primers P15 + P16
and P17 + P18 respectively and inserted into pDONR207 (Table S10).
The full length coding sequence for CYP72A65 (Medtr8g042000) was
ampliﬁed from M. truncatula cDNA using primers P19 and P20 and then
inserted into pDONR221 (Thermo Fisher). All constructs were se-
quenced within the Entry vector to verify the integrity of the clones
(performed by Euroﬁns Genomics). The CYP88D6 entry clone (Seki
et al., 2008) was kindly donated by Prof. Toshiya Muranaka. Entry
clones for CYP716A12 (Moses et al., 2014b) and CYP93E1 (Moses et al.,
2014c) were used as previously described.
Genes were cloned from the relevant Entry vectors into pEAQ-HT-
DEST1 using LR clonase II enzyme (Invitrogen) according to the man-
ufacturer's instructions. An expression construct containing GFP in
pEAQ-HT-DEST1 (Sainsbury et al., 2009) was kindly provided by the
Lomonossoﬀ laboratory (John Innes Centre, UK). The expression con-
structs were transformed into chemically competent Agrobacterium tu-
mefaciens strain LBA4404 by ﬂash freezing in liquid nitrogen.
4.2. Agro-inﬁltration
A. tumefaciens strains carrying the relevant constructs were cul-
tured and prepared for inﬁltration as described previously (Sainsbury
et al., 2012) except that the OD600 of the cells in MMA buﬀer was ad-
justed to 0.2 x n, depending on the number of cultures (n) to be coin-
ﬁltrated. Bacterial suspensions were always combined in equal volumes
for coinﬁltration. N. benthamiana plants were grown as in Sainsbury
et al. (2012). Inﬁltration by syringe was performed as previously de-
scribed (Sainsbury et al., 2012). For vacuum inﬁltration, the inﬁltration
apparatus was constructed from a vacuum oven (LTE Scientiﬁc) which
formed the inﬁltration chamber. The oven was connected to a pump via
a vacuum reservoir (AVE) to reduce the time required to achieve the
desired vacuum in the inﬁltration chamber. Plants were secured within
a bespoke holder and inverted into a stainless steel water bath con-
taining 10 L of A. tumefaciens suspension, ensuring that the aerial parts
were completely submerged. The water bath was sealed within the
vacuum chamber, and the vacuum applied for approximately one
minute until the pressure had been reduced by 880 mbar. The in-
ﬁltration chamber was then quickly returned back to atmospheric
pressure resulting in inﬁltration of the bacterial suspension. Inﬁltrated
leaves were harvested after 5 days.
4.3. Quantiﬁcation of β-amyrin and EpHβA in N. benthamiana leaf extracts
Inﬁltrated N. benthamiana leaves were harvested and 12 mm leaf
disks were punched and frozen at −80 °C. The disks were lyophilized,
weighed and transferred to 2 mL GC-MS autosampler vials (Agilent).
Standard solutions of β-amyrin (Extrasynthese) and EpHβA (this study)
were made to a concentration of 0.5 mg/mL in EtOH and used to make
ten 2-fold dilutions, which when dried gave a calibration series from
50 μg down to ~0.1 μg. These steps were performed using a Gerstel
MultiPurpose Sampler (MPS) to minimize pipetting errors. A saponiﬁ-
cation solution (EtOH:H2O:KOH 9:1:1 v: v:w) was prepared containing
the internal standard (coprostan-3-ol, Sigma-Aldrich) to a ﬁnal con-
centration of 10 μg/mL. Aliquots (500 μL) were pipetted into each
sample vial (leaf disks and standards) using the Gerstel MPS. Samples
were incubated at 65 °C for 2 h with intermittent agitation. 250 μL of
H2O was added to each sample and vortexed before addition of 500 μL
hexane. Samples were vortexed (2 × 10 s) and 100 μL of the upper
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hexane phase transferred to a fresh vial and dried. GC-MS analysis was
performed as described in section 3.5 and data analyzed using Agilent
MassHunter Quantiﬁcation software. Quantiﬁcation of β-amyrin and
EpHβA was achieved relative to the external standard calibration
curves. Quantiﬁer ions for coprostan-3-ol (370), β-amyrin (218) and
EpHβA (189) were used. Quantiﬁcation values were divided by the
weight of the original leaf disk to calculate yield per gram of dry leaf
weight. Graphs were constructed using GraphPad Prism (version 5).
Statistics were performed using one-way ANOVA with post-hoc analysis
(Tukey's multiple comparisons test).
4.4. Combinatorial triterpene biosynthesis
Five-week-old plants were inﬁltrated using three leaves per plant as
replicates. For each combination, four A. tumefaciens strains were co-
inﬁltrated including two carrying tHMGR and Sad1 along with two
strains carrying the relevant CYP genes (where a single CYP was used,
GFP was included in place of the second CYP). Leaves were harvested 5
days after inﬁltration and lyophilized. For extraction, a single 15 mm
leaf disk was taken from each dried leaf and 500 μL EtOAc [containing
10 μg/mL coprostan-3-ol (Sigma-Aldrich)] added to each sample. Leaf
tissue was disrupted by shaking with a single 3 mm tungsten carbide
bead (Qiagen). Samples were incubated at room temperature with
gentle shaking for 2 h. Aliquots (50 μL) were taken from each sample,
transferred to a separate vial and dried under N2. GC-MS analysis was
performed as described in section 3.5 and samples analyzed using
Agilent MassHunter Qualitative Analysis software. New products were
identiﬁed by overlaying the total ion chromatograms of the combina-
torial samples with their relevant single CYP controls (see Fig. S4-S13).
A summary of the combinatorial biosynthesis results is provided in
Table S1.
4.5. GC-MS analysis of leaf extracts
Dried samples were derivatized using Tri-Sil Z reagent (Sigma-
Aldrich) and diluted in an equivalent volume of ethyl acetate prior to
GC-MS analysis. GC was performed using an Agilent 7890B ﬁtted with a
Zebron ZB5-HT Inferno column (Phenomenex). Injections were per-
formed in pulsed splitless mode (30 psi pulse pressure) with the inlet
temperature set to 250 °C. The GC oven temperature program was
170 °C and held for 2 mins with subsequent increase to 300 °C (20 °C/
min) and held at 300 °C for an additional 11.5 min (total run time
20 min). The GC oven was coupled to an Agilent 5977 A Mass Selective
Detector set to scan mode from 60 to 800 mass units (solvent delay
8 min). For quantiﬁcation, the detector was set to 7.2 scans/sec.
4.6. Triterpene puriﬁcation
Inﬁltrations were performed as described in section 3.2 using six-
week-old N. benthamiana plants. A summary of inﬁltrated A. tumefaciens
strains, plant quantities and product yields is provided in Table S2.
Details of puriﬁcation of speciﬁc products are provided in
Supplementary Information.
4.7. NMR analysis
NMR spectra were recorded in Fourier transform mode at a nominal
frequency of 400 MHz for 1H NMR and 100 MHz for 13C NMR, using the
speciﬁed deuterated solvent. Chemical shifts were recorded in ppm and
referenced to the residual solvent peak or to an internal TMS standard.
Multiplicities are described as, s = singlet, d = doublet, dd = doublet
of doublets, dt = doublet of triplets, t = triplet, q = quartet, m =
multiplet, br = broad, appt = apparent; coupling constants are re-
ported in hertz as observed and not corrected for second order eﬀects.
NMR data are provided as supplementary information.
4.8. Yeast strains and metabolite analysis
Yeast strains for combinatorial biosynthesis were generated from
strain PA14 (Miettinen et al., 2017). Strain 1 (Table S9) was generated
by transforming PA14 with a yeast expression construct harboring the
Glycyrrhiza glabra β-amyrin synthase GgbAS, the M. truncatula cyto-
chrome P450 reductase (MTR1) and the truncated S. cerevisiae HMGR1,
pESC-URA[GAL1/GgbAS T2A MTR1; GAL10/tHMG1] (Miettinen et al.,
2017). For generating CYP yeast expression vectors, the Gateway Entry
vectors carrying CYP51H10, CYP88D6, CYP72A65 and CYP716A12 as
described in section 3.1 were used. A vector carrying the functionally
equivalent CYP93E9 (Moses et al., 2014c) was used in place of
CYP93E1. These were recombined into both yeast expression destina-
tion vectors pAG423GAL-ccdB (Addgene plasmid 14149 (Alberti et al.,
2007)) and pAG425GAL-ccdB (Addgene plasmid 14153 (Alberti et al.,
2007)). These vectors were transformed into PA14 and the yeast strains
cultivated in the presence of methyl-β-cyclodextrins (MβCD) as pre-
viously described (Moses et al., 2014b). Aliquots (10 mL) of spent yeast
culture medium were extracted twice with 5 mL hexane and then with
5 mL of ethyl acetate. The resulting organic extracts were pooled and
evaporated to dryness. Samples were derivatized with 50 μL of N-me-
thyl-N-(trimethylsilyl) triﬂuoroacetamide (Sigma-Aldrich) and 10 μL of
pyridine. GC-MS analysis was carried out as previously described
(Moses et al., 2014b).
4.9. Bioactivity assays
β-Amyrin, oleanolic acid, erythrodiol and 18β-glycyrrhetinic acid
were purchased as dry powders from Extrasynthese. Bardoxolone-me-
thyl was purchased as a dry powder from SelleckChem. Products pur-
iﬁed from N. benthamiana were dried under vacuum for 24 h to ensure
removal of trace solvents. Stock solutions of 10 or 20 mM were made in
DMSO under sterile conditions. Eight two-fold serial dilutions of these
stocks were then made (in DMSO) for use in bioassays. Sterile condi-
tions were maintained throughout all subsequent experiments. HL60
and THP-1 cell lines were obtained from the European Collection of
Authenticated Cell Cultures (ECACC). These were maintained in
Roswell Park Memorial Institute (RPMI) 1640 media (Hyclone) sup-
plemented with 10% heat inactivated bovine fetal calf serum (Hyclone),
L-glutamine (2 mM) and antibiotics (penicillin 100 U/mL; streptomycin
(100 μg/mL) (Gibco). Cultures were maintained at 37 °C in a humidi-
ﬁed atmosphere with 5% CO2 and passaged every 3.5 days. Cell den-
sities were measured using a Malassez hemocytometer under a light
microscope and diluted by addition of fresh media to the densities
described below.
For anti-proliferation assays, HL60 cells were seeded at a density of
3x105 cells/mL in 100 μL aliquots in 96 well plates (3x104 cells per
well). To each 100 μL well, 1 μL of the test compound was added from
the series of stock solutions described above to give the ﬁnal test con-
centration (in the micromolar range). Each plate included controls of
untreated cells, vehicle (DMSO)-treated controls and media only-wells.
Following addition of the compounds, the cells were incubated for 72 h
at 37 °C (with 5% CO2). Cell proliferation was determined using a Cell
Titer 96 Aqueous non-radioactive assay; (Promega). MTS reagent was
added to the wells and incubated for 4 h before measuring absorbance
at 492 nm. Absorbance values were corrected by subtracting the media-
only control. IC50 values were calculated using non-linear regression
analysis performed in GraphPad Prism software (version 5).
For the anti-inﬂammatory assays, THP-1 cells were seeded at a
density of 1x106 cells/mL in 500 μL aliquots (5x105 cells per well). Test
compounds (100 μM aliquots) were added to the appropriate wells and
the cells incubated for 30 min at 37 °C (5% CO2). After this time, 1 μL of
LPS (Merck Millipore) was added (from a 0.5 mg/mL stock solution in
RPMI medium) to the appropriate wells to stimulate TNFα production.
The cells were incubated for a further 3 h before pelleting by cen-
trifugation (2000 rpm, 5 min). Supernatants were harvested,
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transferred to fresh tubes on ice, and stored at−80 °C until needed. The
TNFα ELISA was performed using a Human TNF ELISA kit (BD
Biosciences) according to the manufacturer's instructions. Aliquots
(100 μL) of the supernatants (diluted 4-fold) and standards were added
to the ELISA plate. A TNFα standard (BD Biosciences) was prepared
across a two-fold serial dilution range from 500 pg/mL to 7.8 pg/mL
(diluted in phosphate buﬀered saline solution: per liter: 8 g NaCl, 1.17 g
Na2HPO4, 0.2 g KH2PO4, 0.2 g KCl) and used to generate a standard
curve for determining TNFα production. Plates were incubated at room
temperature for 2 h before washing and detection of TNFα with anti-
bodies using the TMB substrate reagent kit (BD Biosciences) according
to the manufacturer's instructions. The absorbance of the samples was
measured at 450 nm with subtraction of absorption values at 570 nm.
Quantiﬁcation of TNFα in each sample was performed by linear re-
gression analysis of the standard curve using GraphPad Prism (version
5). Statistical analysis was performed using a one-way ANOVA test with
post-hoc analysis (Tukey's multiple comparisons test).
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